ASSURE Wearable ECG vs Viz AAA
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A (ASSURE Wearable ECG) is designed for continuous, non-invasive heart rate monitoring and data collection for general cardiac risk management, utilizing a wearable device and remote platform. In contrast, Tool B (Viz AAA) is an AI-powered solution focused on the rapid detection and triage of suspected Abdominal Aortic Aneurysm from CT angiography scans. While both leverage AI in cardiology, they address distinct clinical problems with different data modalities and deployment strategies.
Choose ASSURE Wearable ECG if…
Choose ASSURE Wearable ECG if your priority is continuous, long-term heart rate monitoring and data collection for at-risk cardiac patients in an outpatient setting. This tool is ideal for clinicians needing to remotely track physiological trends, receive alert-based notifications, and review comprehensive ECG data to manage chronic cardiac conditions effectively.
View ASSURE Wearable ECG →Choose Viz AAA if…
Choose Viz AAA if your primary need is the rapid, AI-powered detection and triage of suspected Abdominal Aortic Aneurysm (AAA) directly from CT angiography scans. This solution is best suited for emergency departments and radiology teams requiring accelerated diagnosis, real-time alerts, and streamlined care coordination for time-sensitive vascular pathologies.
View Viz AAA →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ASSURE Wearable ECG | Viz AAA |
|---|---|---|
| Pricing | Contact for pricing. | Enterprise (hospital/health system) |
| Deployment | Wearable device, mobile application, and cloud-based remote patient data platform. | Cloud-based, integrates with PACS and EHR systems. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ASSURE Wearable ECG | Viz AAA |
|---|---|---|
| Name | ASSURE Wearable ECG | Viz AAA |
| Primary Function | Non-therapeutic device for continuous heart rate monitoring and data collection for at-risk cardiac patients. | AI-powered solution for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans. |
| Target Condition/Disease | At-risk cardiac patients (for continuous monitoring) | Suspected Abdominal Aortic Aneurysm (AAA) |
| Key Detection/Monitoring Technology | ASSURE Detection Algorithm with Quad Channel Processingu2122, Adaptive Patient Intelligenceu2122 for filtering motion artifacts. | AI-powered automatic detection of suspected AAA from CTA scans. |
| Alerts & Communication | Alert-based notifications, Kestra CareStation remote patient data platform for clinician review. | Automated triage and prioritization of cases, Real-time alerts to care teams, HIPAA-compliant communication platform for multidisciplinary teams. |
| Specialties Served | Cardiology | Emergency Medicine, Radiology, Vascular Surgery |
Videos
Demos, reviews, and walkthroughs featuring ASSURE Wearable ECG and Viz AAA.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
Viz AAA is designed for integration into existing hospital workflows, providing real-time alerts to care teams and mobile access to high-fidelity imaging and patient information, which can accelerate treatment decisions. Kestra's ASSURE Wearable ECG integrates with the Kestra CareStation remote patient data platform for clinician review, offering automatic episode storage, alert-based notifications, and physiologic trend data.
Viz AAA has demonstrated high accuracy, with studies reporting sensitivity greater than 85% (86.5% or 88.6%) and specificity of 98.3% for detecting AAA from CTA scans. The ASSURE Wearable ECG utilizes a Quad Channel Processingu2122 algorithm and Adaptive Patient Intelligenceu2122 to filter motion artifacts and improve ECG signal quality for continuous heart rate monitoring.
Viz AAA, as part of the Viz AORTIC Module, facilitates multidisciplinary team communication and care coordination for various aortic pathologies, potentially improving patient outcomes by accelerating treatment decisions. The ASSURE Wearable ECG supports continuous monitoring and trend data, which can be valuable for managing at-risk cardiac patients in community settings and for timely intervention in complex cardiac recovery scenarios.
For Viz AAA, the integration into existing hospital workflows and real-time alerts are designed to streamline processes, suggesting a relatively quick adoption for care teams to leverage its benefits for accelerated diagnosis and care coordination. Kestra's ASSURE Wearable ECG involves a wearable device and a patient app, with patient training provided by Kestra service representatives, aiming for ease of use and high patient compliance to quickly yield continuous monitoring data for clinicians.
The ASSURE Wearable ECG system includes automatic episode storage and physiologic trend data, and its platform features audit logs for tracking data. Viz AAA's automated triage and real-time alerts imply a system that logs actions and communications, which is crucial for accountability and quality improvement in rapid care coordination scenarios.
Kestra Medical Technologies offers an ASSURE Helpline for both patients and providers, indicating direct support channels. Viz.ai works with leading hospitals and healthcare providers to implement Viz AAA into their clinical workflows, suggesting a collaborative approach and potential for customer references.
More Comparisons
More matchups featuring ASSURE Wearable ECG or Viz AAA
Backers
Who funded each tool's parent company.